Clinical trials update: highlights of the scientific sessions of the XXIII Congress of the European Society of Cardiology - WARIS II, ESCAMI, PAFAC, RITZ-1 and TIME

被引：52

作者：

Coletta, AP ^{[1
]}

Cleland, JGF ^{[1
]}

机构：

[1] Castle Hill Hosp, Dept Acad Cardiol, Kingston Upon Hull HU16 5JQ, Yorks, England

来源：

EUROPEAN JOURNAL OF HEART FAILURE | 2001年 / 3卷 / 06期

关键词：

heart failure; cardiology; WARIS II; ESCAMI; PAFAC; RITZ-1; TIME;

D O I：

10.1016/S1388-9842(01)00210-0

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

This article continues a series of reports updating recent research developments of particular interest to personnel involved in the treatment and management of patients with heart failure. This is a summary of selected presentations made at the Scientific Sessions of the XXIII Annual Congress of the European Society of Cardiology. Summaries of the following clinical studies are included: WARIS-II, ESCAMI, PAFAC, RITZ-I and TIME. (C) 2001 European Society of Cardiology. All rights reserved.

引用

页码：747 / 750

页数：4

共 9 条

[1] Endothelin antagonists for chronic heart failure: do they have a role? [J].

Cowburn, PJ ;

Cleland, JGF .

EUROPEAN HEART JOURNAL, 2001, 22 (19) :1772-1784

[2]

Fetsch T, 1999, Z KARDIOL, V88, P195, DOI 10.1007/s003920050276

[3]

Hurlen M, 2000, SCAND CARDIOVASC J, V34, P168

[4] Representation of elderly persons and women in published randomized trials of acute coronary syndromes [J].

Lee, PY ;

Alexander, KP ;

Hammill, BG ;

Pasquali, SK ;

Peterson, ED .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (06) :708-713

[5] Clinical Trials Update: CAPRICORN, COPERNICUS, MIRACLE, STAF, RITZ-2, RECOVER and RENAISSANCE and cachexia and cholesterol in heart failure. Highlights of the Scientific Sessions of the American College of Cardiology, 2001 [J].

Louis, A ;

Cleland, JGF ;

Crabbe, S ;

Ford, S ;

Thackray, S ;

Houghton, T ;

Clark, A .

EUROPEAN JOURNAL OF HEART FAILURE, 2001, 3 (03) :381-387

[6] Clinical trials update: highlights of the scientific sessions of the American heart association year 2000: Val HeFT, COPERNICUS, MERIT, CIBIS-II, BEST, AMIOVIRT, V-MAC, BREATHE, HEAT, MIRACL, FLORIDA, VIVA and the first human cardiac skeletal muscle myoblast transfer for heart failure [J].

Thackray, SDR ;

Witte, KKA ;

Khand, A ;

Dunn, A ;

Clark, AL ;

Cleland, JGF .

EUROPEAN JOURNAL OF HEART FAILURE, 2001, 3 (01) :117-124

[7]

*TIME INV, 2001, HEART DRUG, V1, P144

[8] Clinical trials update: IMPROVEMENT-HF, COPERNICUS, MUSTIC, ASPECT-II, APRICOT and HEART [J].

Witte, K ;

Thackray, S ;

Clark, AL ;

Cooklin, M ;

Cleland, JGF .

EUROPEAN JOURNAL OF HEART FAILURE, 2000, 2 (04) :455-460

[9]

Zeymer Uwe, 2001, HeartDrug, V1, P71, DOI 10.1159/000048940

← 1 →